Wednesday, June 26, 2013
INCREASE PATCHING TIME IN AMBLYOPIA
This study in Ophthalmology concludes:
Wednesday, June 19, 2013
SIMBRINZA FDA APPROVED
Simbrinza is made by Alcon and is the combination of brinzolamide (Azopt) and brimonidine (Alphagan). It is contraindicated in patients with sulfa allergies. Alcon claims that the suspension provides 1-3mmHg of additional IOP lowering affect when compared to the individual components. Dosage is TID and because it's a suspension, it should be shaken well.
Subscribe to:
Posts (Atom)